André Luís Borges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
André Luís Borges has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Patrícia Pinto
Serviço de Ginecologia Oncológica, Instituto Português de Oncologia de Lisboa-Dr. Francisco Gentil, 1099-023 Lisboa, Portugal
2 shared publications A. I. Gouveia
Faculdade de Ciências da Saúde Universidade da Beira Interior Covilhã Portugal
1 shared publication- Abílio Lacerda
Maternidade Dr. Alfredo da Costa, Centro Hospitalar Universitário Lisboa Central (CHULC), 2890-495 Lisbon, Portugal
1 shared publication Ana Martins
Obstetrics and Gynecology Department, Hospital de São Francisco Xavier-Centro Hospitalar de Lisboa Ocidental, Estrada Forte do Alto Duque, Edificio 2 Piso 3, Lisboa, 1449-005, Portugal
1 shared publication- Ana Ruivo
Surgery Department, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal
1 shared publication - Ana Sofia Domingos
Unidade Local de Saúde Lezíria - Hospital Distrital de Santarém, Santarém, Portugal
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (5) , 1-21
First Touch course—the impact of a nation-wide boot camp on the transition to Surgical residency
Surgical residents face numerous challenges and undergo significant changes at the beginning of their residency. Although there are several courses throughout residency, it is difficult to address all of them in a single activity. Boot camps (BC) have been a way for easing this transition period. Our team developed the “First Touch Course” boot camp in 2017 to join all residents of the same year, before they initiate Surgical residency. Since then, 8 editions have been organised (one per year) with the participation of a total of 481 residents. Eighty-four residents have enrolled in the last two editions, mainly from General Surgery, Gynecology and Urology. The present study analysed the 2023 and 2024 editions to evaluate the impact of this BC on residents’ preparedness and confidence to face residency. More than 71% of the participants rated the course as excellent and 100% considered it exceeded their expectations. Almost 100% considered it will have a significant impact and more than 75% felt better prepared to start residency after the course. More than 73% believe that having a laparoscopic simulator will be useful for continuous skills acquisition. This is the first nationwide, multi-speciality boot camp that promotes continuing education, providing each resident with a personal laparoscopy simulator and laparoscopic instruments, allowing for home-based training. This study highlights the importance and impact of this kind of boot camps in preparing residents for the early stages of surgical residency and the impact it may have on basic skills acquisition. Graphical Abstract
- 30 June 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (5) , 1-21
Open AccessFirst Touch course—the impact of a nation-wide boot camp on the transition to Surgical residency
Surgical residents face numerous challenges and undergo significant changes at the beginning of their residency. Although there are several courses throughout residency, it is difficult to address all of them in a single activity. Boot camps (BC) have been a way for easing this transition period. Our team developed the “First Touch Course” boot camp in 2017 to join all residents of the same year, before they initiate Surgical residency. Since then, 8 editions have been organised (one per year) with the participation of a total of 481 residents. Eighty-four residents have enrolled in the last two editions, mainly from General Surgery, Gynecology and Urology. The present study analysed the 2023 and 2024 editions to evaluate the impact of this BC on residents’ preparedness and confidence to face residency. More than 71% of the participants rated the course as excellent and 100% considered it exceeded their expectations. Almost 100% considered it will have a significant impact and more than 75% felt better prepared to start residency after the course. More than 73% believe that having a laparoscopic simulator will be useful for continuous skills acquisition. This is the first nationwide, multi-speciality boot camp that promotes continuing education, providing each resident with a personal laparoscopy simulator and laparoscopic instruments, allowing for home-based training. This study highlights the importance and impact of this kind of boot camps in preparing residents for the early stages of surgical residency and the impact it may have on basic skills acquisition. Graphical Abstract
- 4 September 2024
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 64 (4) , 538-549
Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two‐step strategy using benign descriptors and ADNEX model: Portuguese multicenter study
Objectives: To externally and prospectively validate the International Ovarian Tumor Analysis (IOTA) Simple Rules (SRs), Logistic Regression model 2 (LR2) and Assessment of Different NEoplasias in the adneXa (ADNEX) model in a Portuguese population, comparing these approaches with subjective assessment and the risk‐of‐malignancy index (RMI), as well as with each other. This study also aimed to retrospectively validate the IOTA two‐step strategy, using modified benign simple descriptors (MBDs) followed by the ADNEX model in cases in which MBDs were not applicable.Methods: This was a prospective multicenter diagnostic accuracy study conducted between January 2016 and December 2021 of consecutive patients with an ultrasound diagnosis of at least one adnexal tumor, who underwent surgery at one of three tertiary referral centers in Lisbon, Portugal. All ultrasound assessments were performed by Level‐II or ‐III sonologists with IOTA certification. Patient clinical data and serum CA 125 levels were collected from hospital databases. Each adnexal mass was classified as benign or malignant using subjective assessment, RMI, IOTA SRs, LR2 and the ADNEX model (with and without CA 125). The reference standard was histopathological diagnosis. In the second phase, all adnexal tumors were classified retrospectively using the two‐step strategy (MBDs + ADNEX). Sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios and overall accuracy were determined for all methods. Receiver‐operating‐characteristics curves were constructed and corresponding areas under the curve (AUC) were determined for RMI, LR2, the ADNEX model and the two‐step strategy. The ADNEX model calibration plots were constructed using locally estimated scatterplot smoothing (LOESS).Results: Of the 571 patients included in the study, 428 had benign disease and 143 had malignant disease (prevalence of malignancy, 25.0%), of which 42 had borderline ovarian tumor, 93 had primary invasive adnexal cancer and eight had metastatic tumors in the adnexa. Subjective assessment had an overall sensitivity of 97.9% and a specificity of 83.6% for distinguishing between benign and malignant lesions. RMI showed high specificity (95.6%) but very low sensitivity (58.7%), with an AUC of 0.913. The IOTA SRs were applicable in 80.0% of patients, with a sensitivity of 94.8% and specificity of 98.6%. The IOTA LR2 had a sensitivity of 84.6%, specificity of 86.9% and an AUC of 0.939, at a malignancy risk cut‐off of 10%. At the same cut‐off, the sensitivity, specificity and AUC for the ADNEX model with vs without CA 125 were 95.8% vs 98.6%, 82.5% vs 79.7% and 0.962 vs 0.960, respectively. The ADNEX model gave heterogeneous results for distinguishing between benign masses and different subtypes of malignancy, with the highest AUC (0.991) for discriminating benign masses from primary invasive adnexal cancer Stages II–IV, and the lowest AUC (0.696) for discriminating primary invasive adnexal cancer Stage I from metastatic lesion in the adnexa. The calibration plot suggested underestimation of the risk by the ADNEX model compared with the observed proportion of malignancy. The MBDs were applicable in 26.3% (150/571) of cases, of which none was malignant. The two‐step strategy using the ADNEX model in the second step only, with and without CA 125, had AUCs of 0.964 and 0.961, respectively, which was similar to applying the ADNEX model in all patients.Conclusions: The IOTA methods showed good‐to‐excellent performance in the Portuguese population, outperforming RMI. The ADNEX model was superior to other methods in terms of accuracy, but interpretation of its ability to distinguish between malignant subtypes was limited by sample size and large differences in the prevalence of tumor subtypes. The IOTA MBDs are reliable in identifying benign disease. The two‐step strategy comprising application of MBDs followed by the ADNEX model if MBDs are not applicable, is suitable for daily clinical practice, circumventing the need to calculate the risk of malignancy in all patients. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
- 4 September 2024
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 64 (4) , 538-549
Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two‐step strategy using benign descriptors and ADNEX model: Portuguese multicenter study
Objectives: To externally and prospectively validate the International Ovarian Tumor Analysis (IOTA) Simple Rules (SRs), Logistic Regression model 2 (LR2) and Assessment of Different NEoplasias in the adneXa (ADNEX) model in a Portuguese population, comparing these approaches with subjective assessment and the risk‐of‐malignancy index (RMI), as well as with each other. This study also aimed to retrospectively validate the IOTA two‐step strategy, using modified benign simple descriptors (MBDs) followed by the ADNEX model in cases in which MBDs were not applicable.Methods: This was a prospective multicenter diagnostic accuracy study conducted between January 2016 and December 2021 of consecutive patients with an ultrasound diagnosis of at least one adnexal tumor, who underwent surgery at one of three tertiary referral centers in Lisbon, Portugal. All ultrasound assessments were performed by Level‐II or ‐III sonologists with IOTA certification. Patient clinical data and serum CA 125 levels were collected from hospital databases. Each adnexal mass was classified as benign or malignant using subjective assessment, RMI, IOTA SRs, LR2 and the ADNEX model (with and without CA 125). The reference standard was histopathological diagnosis. In the second phase, all adnexal tumors were classified retrospectively using the two‐step strategy (MBDs + ADNEX). Sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios and overall accuracy were determined for all methods. Receiver‐operating‐characteristics curves were constructed and corresponding areas under the curve (AUC) were determined for RMI, LR2, the ADNEX model and the two‐step strategy. The ADNEX model calibration plots were constructed using locally estimated scatterplot smoothing (LOESS).Results: Of the 571 patients included in the study, 428 had benign disease and 143 had malignant disease (prevalence of malignancy, 25.0%), of which 42 had borderline ovarian tumor, 93 had primary invasive adnexal cancer and eight had metastatic tumors in the adnexa. Subjective assessment had an overall sensitivity of 97.9% and a specificity of 83.6% for distinguishing between benign and malignant lesions. RMI showed high specificity (95.6%) but very low sensitivity (58.7%), with an AUC of 0.913. The IOTA SRs were applicable in 80.0% of patients, with a sensitivity of 94.8% and specificity of 98.6%. The IOTA LR2 had a sensitivity of 84.6%, specificity of 86.9% and an AUC of 0.939, at a malignancy risk cut‐off of 10%. At the same cut‐off, the sensitivity, specificity and AUC for the ADNEX model with vs without CA 125 were 95.8% vs 98.6%, 82.5% vs 79.7% and 0.962 vs 0.960, respectively. The ADNEX model gave heterogeneous results for distinguishing between benign masses and different subtypes of malignancy, with the highest AUC (0.991) for discriminating benign masses from primary invasive adnexal cancer Stages II–IV, and the lowest AUC (0.696) for discriminating primary invasive adnexal cancer Stage I from metastatic lesion in the adnexa. The calibration plot suggested underestimation of the risk by the ADNEX model compared with the observed proportion of malignancy. The MBDs were applicable in 26.3% (150/571) of cases, of which none was malignant. The two‐step strategy using the ADNEX model in the second step only, with and without CA 125, had AUCs of 0.964 and 0.961, respectively, which was similar to applying the ADNEX model in all patients.Conclusions: The IOTA methods showed good‐to‐excellent performance in the Portuguese population, outperforming RMI. The ADNEX model was superior to other methods in terms of accuracy, but interpretation of its ability to distinguish between malignant subtypes was limited by sample size and large differences in the prevalence of tumor subtypes. The IOTA MBDs are reliable in identifying benign disease. The two‐step strategy comprising application of MBDs followed by the ADNEX model if MBDs are not applicable, is suitable for daily clinical practice, circumventing the need to calculate the risk of malignancy in all patients. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
- Open Access
- 31 August 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (11) , 5393-5398
A familial case of diffuse periventricular nodular heterotopia identified prenatally: Filamin A defect as the probable cause
- 31 August 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (11) , 5393-5398
Open AccessA familial case of diffuse periventricular nodular heterotopia identified prenatally: Filamin A defect as the probable cause
- Open Access
- 7 June 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (8) , 2771-2784
Herlyn-Werner-Wunderlich syndrome also known as obstructed hemivagina and ipsilateral renal anomaly: A case report and a comprehensive review of literature
- 7 June 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (8) , 2771-2784
Open AccessHerlyn-Werner-Wunderlich syndrome also known as obstructed hemivagina and ipsilateral renal anomaly: A case report and a comprehensive review of literature
- Open Access
- 27 October 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (11) , 1992
Conservative Management of Asymptomatic Adnexal Masses Classified as Benign by the IOTA ADNEX Model: A Prospective Multicenter Portuguese Study
This prospective multicentric study aiming to determine the incidence of complications (malignant transformation, torsion or rupture) during conservative management of adnexal masses was performed in two Portuguese tertiary referral hospitals. It included ≥18-year-old, non-pregnant patients with asymptomatic adnexal masses (associated IOTA ADNEX risk of malignancy < 10%) sonographically diagnosed between January 2016 and December 2020. Conservative patient management consisted of serial clinical and ultrasound assessment up to 60 months of follow-up, spontaneous resolution of the formation or surgical excision (median follow-up: 17.8; range 9–48 months). From the 573 masses monitored (328 premenopausal and 245 postmenopausal adnexal masses), no complications were observed in 99.5%. The annual lesion growth rates and increases in morphological complexity were similar in the premenopausal and postmenopausal patients. Spontaneous resolution, evidenced in 16.4% of the patients, was more common in the premenopausal group (p < 0.05). Surgical intervention was performed in 18.4% of the cases; one borderline and one invasive FIGO IA stage cancer were diagnosed. There was an isolated case of ovary torsion (0.17%). These data support conservative management as a safe option for sonographically benign, stable and asymptomatic adnexal masses before and after menopause and highlight the need for expedite treatment of symptomatic or increased-morphological-complexity lesions.
- 27 October 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (11) , 1992
Open AccessConservative Management of Asymptomatic Adnexal Masses Classified as Benign by the IOTA ADNEX Model: A Prospective Multicenter Portuguese Study
This prospective multicentric study aiming to determine the incidence of complications (malignant transformation, torsion or rupture) during conservative management of adnexal masses was performed in two Portuguese tertiary referral hospitals. It included ≥18-year-old, non-pregnant patients with asymptomatic adnexal masses (associated IOTA ADNEX risk of malignancy < 10%) sonographically diagnosed between January 2016 and December 2020. Conservative patient management consisted of serial clinical and ultrasound assessment up to 60 months of follow-up, spontaneous resolution of the formation or surgical excision (median follow-up: 17.8; range 9–48 months). From the 573 masses monitored (328 premenopausal and 245 postmenopausal adnexal masses), no complications were observed in 99.5%. The annual lesion growth rates and increases in morphological complexity were similar in the premenopausal and postmenopausal patients. Spontaneous resolution, evidenced in 16.4% of the patients, was more common in the premenopausal group (p < 0.05). Surgical intervention was performed in 18.4% of the cases; one borderline and one invasive FIGO IA stage cancer were diagnosed. There was an isolated case of ovary torsion (0.17%). These data support conservative management as a safe option for sonographically benign, stable and asymptomatic adnexal masses before and after menopause and highlight the need for expedite treatment of symptomatic or increased-morphological-complexity lesions.